DBV Technologies (DBVT) Current Leases (2019 - 2026)
DBV Technologies (DBVT) posted quarterly Current Leases of $800000.0 for Q2 2026, down 19.84% year-on-year from $998000.0 in Q2 2025, and down 20.0% on a QoQ basis from $1.0 million in Q1 2026.
DBV Technologies (DBVT) Current Leases (2019 - 2026) Analysis & Trends
DBV Technologies (DBVT) has reported Current Leases for 8 consecutive years, with $800000.0 the latest figure, recorded in Q2 2026.
- Quarterly Current Leases fell 19.84% year-over-year to $800000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $800000.0 (down 19.84% YoY) and the FY2025 annual result came in at $1.1 million, up 68.2% from the prior year.
- Current Leases eased to $800000.0 in Q2 2026 per DBVT's latest filing, from $1.0 million in the prior quarter.
- Over the last five years, Current Leases for DBVT reached as high as $2.0 million in Q1 2022 and fell as low as $232000.0 in Q1 2024.
- A 5-year average of $1.2 million and a median of $1.1 million in 2025 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2024 — Current Leases sank 87.94% — and 2025, when it jumped 205.6%.
- Year by year, Current Leases stood at $1.9 million in 2022, then tumbled by 39.6% to $1.1 million in 2023, then slumped by 42.83% to $654000.0 in 2024, then jumped by 68.2% to $1.1 million in 2025, then declined by 27.27% to $800000.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $800000.0, $1.0 million, and $1.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | 800,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 800,000.00 |
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 998,000.00 |
| Mar 31, 2025 | 709,000.00 |
| Dec 31, 2024 | 654,000.00 |
| Sep 30, 2024 | 374,000.00 |
| Jun 30, 2024 | 380,000.00 |
| Mar 31, 2024 | 232,000.00 |
| Dec 31, 2023 | 1.14 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Jun 30, 2023 | 1.94 Mn |
| Mar 31, 2023 | 1.92 Mn |
| Dec 31, 2022 | 1.89 Mn |
| Sep 30, 2022 | 1.38 Mn |
| Jun 30, 2022 | 1.97 Mn |
| Mar 31, 2022 | 2.03 Mn |
| Dec 31, 2021 | 3.00 Mn |
| Sep 30, 2021 | 2.66 Mn |